Emerging Markets


Key Users

Global Market Research
Global Government Affairs
New Product Planning
Commercial Analysis

The Ultimate Analysis of New and Growing Pharmaceutical Markets

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis.

With these reports, clients are able to:

  • More accurately assess commercial opportunity for Western brands in emerging markets
  • Understand the physician treatment patterns and drivers of choice in key urban areas based on primary research
  • Gain a clear perspective from a 5-year, drug-level market forecast, which is broken out by multinational companies’ sales versus their national competitors

Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians’ practices.

Key elements of each report include:

  • Accurate sizing of and projections for the diagnosed and treated patient populations at national and city-specific levels
  • Projections for future patient populations with access to Western medicine based on trends in lifestyle, urbanization and economic status
  • Current treatment patterns and drivers of choice from physicians in key urban areas
  • Physician-defined unmet needs in diagnosing and treating the disease
  • Disease-specific pricing and reimbursement environment
  • Key drivers of overall market growth and analysis of dynamics unique to the individual major city markets

The following links provide detailed information on the research methodology for our Emerging Markets report series.

Primary Research Methodology

Epidemiology Methodology   

Search Reports

Decision Resources Group Channel Offerings:

Click here for Professional Services including Advertising, Marketing, Consulting, IT and Financial Services

Decision Resources Group brands include: